Vcanbio Cell & Gene Engineering

OverviewSuggest Edit

Vcanbio Cell & Gene Engineering (also known as Zhongyuan Union) is a biotech company focusing on cell therapy, precision medicine, and other related fields. In addition, the company owns cord blood banks.

TypePublic
Founded1992
Websitevcanbio.com

Latest Updates

Employees (est.) (Apr 2020)2,201
Share Price (Jul 2021)¥21.5(+3%)
Cybersecurity ratingDMore

Vcanbio Cell & Gene Engineering Financials and Metrics

Vcanbio Cell & Gene Engineering Revenue

Market capitalization (21-Jul-2021)

9.9b

Closing stock price (21-Jul-2021)

21.5
Vcanbio Cell & Gene Engineering's current market capitalization is ¥9.9 b.
Show all financial metrics

Vcanbio Cell & Gene Engineering Cybersecurity Score

Cybersecurity ratingPremium dataset

D

69/100

SecurityScorecard logo

Vcanbio Cell & Gene Engineering Online and Social Media Presence

Embed Graph

Vcanbio Cell & Gene Engineering Frequently Asked Questions

  • When was Vcanbio Cell & Gene Engineering founded?

    Vcanbio Cell & Gene Engineering was founded in 1992.

  • How many employees does Vcanbio Cell & Gene Engineering have?

    Vcanbio Cell & Gene Engineering has 2,201 employees.

  • Who are Vcanbio Cell & Gene Engineering competitors?

    Competitors of Vcanbio Cell & Gene Engineering include oncomed, Fysius Rugexperts and Right To Care.